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Background: Impaired cognitive control functions have been demonstrated in both major 
depression (MDD) and anxiety disorder (A), but few studies have systematically examined the 
impact of MDD with co-morbid A (MDDA), which is the main aim of this study. Method: We 
compared patients with MDD with (MDDA; n = 24) and without co-morbid A (n = 37) to a group 
of healthy controls (HC; n = 92) on three subtests from the Cambridge Neuropsychological  Test 
Automated Battery; intra–extra dimensional, stop signal task, and spatial working memory.  These 
tasks correspond to a theoretical model consisting of three separable but interrelated executive 
control functions: Shifting, Inhibition, and Updating. A simple psychomotor speed measure was 
also included. Results: After controlling for age, gender, and education level, the results showed 
that the MDDA group displayed significantly impaired performance on the functions Shifting and 
Updating compared to HC.  There emerged no significant differences between any of the patient 
groups and HC regarding Inhibition. The pure MDD group did not display dysfunctions relative 
to the HC group on the main executive control variables, but displayed slowed psychomotor 
speed. Contrary to expectation there were no significant differences between the MDDA and 
the MDD groups. Conclusion: Co-morbid anxiety should be taken into account when studying 
cognitive control functions in major depression.
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2004; Levin et al., 2007; Porter et al., 2007 for reviews). The few stud-
ies distinguishing between unipolar and bipolar depressed patients 
have not displayed a consistent picture (Gruber et al., 2007 ) but 
impaired inhibitory control seem to be more pronounced in bipolar 
versus MDD patients.
Findings link cognitive control deficits in MDD to increase in 
negative affect (McNeely et al., 2005; Dennis and Chen, 2007), a 
tendency to ruminate (Nolen-Hoeksema, 1991), increasing number 
of depressive episodes (Vanderhasselt and De Raedt, 2009), and a 
family history of depression in children (Perez-Edgar et al., 2006; 
Vanderhasselt and De Raedt, 2009).
Cognitive control embodies the ability to organize incoming 
stimuli and inhibit a dominant response in order to perform a 
subdominant response (MacLeod et al., 2002). However, executive 
functions are complex, and because they manifest themselves by 
operating on other cognitive processes, this implicates other cogni-
tive processes not directly relevant to the target executive function, 
hence “the task impurity problem” (Philips, 1997). Executive tasks 
have also tended to suffer from relatively low internal and/or test–
retest reliability (Denckla, 1996; Rabbit, 1997; Miyake et al., 2000), 
and widely used and accepted tests like, i.e., WCST and TOH have 
based their construct validity on loose criteria such as “sensitive 
to frontal lobe damage.” The complexity of the construct is also 
reflected in the myriad of terms and definitions used to charac-
terize executive control functions in addition to the tests used to 
measure them.
IntroductIon
Depressive disorders present a significant mental health concern 
to individuals and to our society. It is estimated that mood disor-
ders will be the most frequent cause of serious health problems 
worldwide in 2020 (WHO). The lifetime risk for major depressive 
disorder (MDD) is between 10 and 25% for women and between 
5 and 12% for men (American Psychiatric Association, 1994).
Affective neuroscience research has been increasingly focus-
ing on cognitive or executive control processes (for a review, see 
Ochsner and Gross, 2005). Investigations of executive control func-
tions are in general relevant across a range of psychiatric disorders, 
like schizophrenia (Wilmsmeier et al., 2010), obsessive compulsive 
disorder (Olley et al., 2007), and bipolar disorder (Daban et al., 
2006). Although these disorders share a common deficit in execu-
tive functions, a main issue is to what degree there are differences 
and similarities along various dimensions of executive functions 
across such disorders.
Retarded psychomotor speed, as measured by simple reaction 
time tests, was traditionally considered a basic clinical character-
istic of unipolar MDD. Although slowed reactions obviously are 
a relevant aspect of the neuropsychological profile in depression 
(Egeland et al., 2005), associated cognitive dysfunctions cover a 
broad range (Burt et al., 1995; Christensen et al., 1997; Kindermann 
and Brown, 1997; Veiel, 1997; Austin et al., 2001; Landrø et al., 2001; 
Porter et al., 2007). Impaired executive cognitive control functions 
seems to be particularly salient (Austin et al., 2001; Rogers et al., 
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the assessment of neuropsychological status (RBANS) in relation 
to the pure depression group. They found no relevant differences in 
mean scores for the depressed group in the study and the depressed 
group in the RBANS validation study. However, the inclusion of a 
healthy control group would give an indication of how the clinical 
groups differ compared to a healthy population.
On the other hand, in a review Levin et al. (2007) states that 
when the noise introduced by unassessed co-morbid anxiety is 
successfully addressed, executive function impairments specific to 
depression can account for many of the cognitive deficits identi-
fied. Similarly, within the context of a population based sample it 
was found that the subgroups of MDD and MDD with co-morbid 
Axis I disorder did not differ on any of the cognitive measures 
assessed, and conclude that psychiatric co-morbidity may not 
aggravate cognitive functioning among depressed young adults 
(Castaneda et al., 2009).
While a substantial number of patients with MDD have co-
morbid anxiety that possibly contributes to cognitive impairments, 
most  patients  with  MDD  also  experience  recurrent  episodes. 
Research on the possible effects of number of episodes on cogni-
tion has yielded inconsistent results regarding whether number of 
recurrent depressive episodes confounds with increased cognitive 
impairment or not (Veiel, 1997; Basso and Bornstein, 1999; Stordal 
et al., 2004). In light of the previous limited research, inconsistent 
results and clinical importance, there is a vital need for further 
research to address these issues.
Although a considerable body of research documents that chil-
dren of depressed parents exhibit higher rates of mood disorders 
than comparison groups (see Klimes-Dougan et al., 2006), there 
are only a few studies that have been directed toward examining 
neurocognitive functioning in this risk group. One of few studies 
that examined family history and executive functions is Klimes-
Dougan et al. (2006) who studied neuropsychological function-
ing in offspring of parents with a history of mood disorders and 
found deficits in, e.g., executive functioning in BPD offspring 
compared to offspring of well mothers. Deficits were not found 
for children of MDD mothers. Still, heritability is estimated as 
high as 70%. Characteristics that have generally been shown to 
predict a larger increase in risk to their relatives are, e.g., recurrent 
episodes (Sullivan et al., 2000) and earlier age at onset (see review 
by Levinson et al., 2003).
The main aim of this study was to investigate basic components 
of cognitive control functions in patients with MDD with or with-
out co-morbid anxiety disorders, and compare to a healthy control 
group. Consistent with prior research regarding neurocognition 
in affective disorders, we expected both patient groups to perform 
worse than the HC, but that the MDDA group would perform 
worse than the MDD without anxiety. Possible effect of number of 
depressive episodes and age of onset first depressive episode was 
also investigated.
MaterIals and Methods
The study was approved by the Regional Committee for Medical 
Research Ethics, Norwegian Social Science Data Services (NSD) 
and adhered to the Helsinki Convention.
Written informed consent was obtained after the participants 
had been provided with a complete description of the study.
In an attempt to minimize the task impurity problem, Miyake 
et al. (2000) used latent variable analysis to determine to what 
extent different executive processes can be considered to be uni-
tary (in the sense that they are reflections of the same underlying 
mechanism or ability) or non-unitary. They focused on the fol-
lowing three basic executive functions: (1) shifting between tasks 
or mental sets, (2) inhibition of dominant or prepotent responses, 
and (3) updating and monitoring the contents of working memory. 
Confirmatory factor analysis indicated that these three executive 
processes, although moderately correlated with one another, are 
clearly separable. The model proposes relatively circumscribed 
lower (basic) level functions compared to many of the wider and 
higher level definitions and general measures of executive function-
ing, thus allowing precision as to which cognitive control functions 
are affected and which are not. However, neuropsychological studies 
of mood disorders based on an empirically based model of basic 
executive control functions are relatively sparse.
There  is  extensive  co-morbidity  between  MDD  and  other 
affective  disorders,  especially  anxiety  disorders  (A),  regarding 
phenomenological features as well as neuropsychological function-
ing. Individuals with depression and co-morbid anxiety disorders 
occur in from 25 to 60% of cases, and are associated with increased 
severity, greater chronicity, slower recovery, increased rates of recur-
rence, greater risk for suicide, and greater psychosocial disability 
(Cameron et al., 2004; Leonardo and Hen, 2006).
Anxiety can potentially confound or contribute to neuropsycho-
logical impairments or anatomic changes in depressed individuals 
(Cameron et al., 2004; Leonardo and Hen, 2006), and is in general 
associated with heightened distractibility, poor concentration, and 
increased responsivity to potential threat (Bishop et al., 2004b). 
Several  studies  have  demonstrated  neuropsychological  deficits 
involving, i.e., executive function, attention, working memory, and 
attentional control to threat-related stimuli in anxiety disorders 
(Broadbent et al., 1986; Asmundson et al., 1994; Cohen et al., 1996; 
Vasterling et al., 2000; Lautenbacher et al., 2002; Danckwerts and 
Leathem, 2003; Ludewig et al., 2003; Bishop et al., 2004b; Basso et al., 
2007). The latter have been demonstrated with emotional Stroop 
(Mathews et al., 1997) and associated with deficits that are particular 
to the execution of attentional inhibition (Fox, 1994). This impaired 
cognitive control over threat-related distractors has also been sup-
ported by fMRI studies (Bishop et al., 2004a).
The effects of co-morbid anxiety in MDD have been systemati-
cally investigated in only a few studies. It has been suggested that 
executive dysfunction and psychomotor slowing are specific to the 
depressed group with co-morbid anxiety (Basso et al., 2007). The 
latter group also displayed more impaired scores than both “pure” 
MDD and HC. The limitations of this study are mainly the reliabil-
ity of patient diagnoses; the data were collected retrospectively from 
available records, and the diagnoses lacked a structural diagnostic 
interview. The patient sample also consisted entirely of inpatients, 
and the literature suggests that inpatients are more severely impaired 
than outpatients (Burt et al., 1995; Christensen et al., 1997; Veiel, 
1997). Corroborating these results, a recent study concluded that 
the strongest predictor of poor cognitive performance in depression 
was psychiatric co-morbidity (Baune et al., 2009). The co-morbid 
group showed decreased cognitive performance in visuospatial and 
language domains and in total score on the repeatable battery for www.frontiersin.org  December 2010  | Volume 1  | Article 149  |  3
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The Beck Depression Inventory (BDI-II; Beck et al., 1961) and 
The Beck Anxiety Inventory (BAI; Beck and Steer, 1988) were filled 
out by the participants to measure severity of depression and anxi-
ety symptoms. General level of functioning were screened using 
Global Assessment of Functions Scale for symptom and function 
(GAF-S and GAF-F; DSM-IV).
General  medical  and  psychiatric  background,  demographic 
information, past episodes of recurrent major depression and family 
medical and psychiatric history were obtained using a semi-struc-
tured interview developed by the first author (Lyche, 2006) based 
on the diagnostic interview for genetic studies (DIGS; Nurnberger 
et al., 1994) and a semi-structured screening instrument developed 
by Biringer (2005), University of Bergen. Education level was clas-
sified by means of The International Standard Classification of 
Education (ISCED; UNESCO, 1997).
General coGnItIve Measures
General cognitive functioning was estimated from the mean of 
two subtests from the WAIS-III: picture completion (PC) and-
similarities (SI) (Wechsler, 1999).
neuropsycholoGIcal assessMent
Three  subtests  from  the  Cambridge  Neuropsychological  Test 
Automated Battery (CANTAB) which measure executive control 
functions according to Miyake et al. (2000) model were adminis-
tered. In addition; a motor screening test (MOT) was administered 
in the beginning of the test session.
The neuropsychological tests were administered by a clinical 
psychologist trained in standardized assessment, or by an experi-
enced test technician.
Cambridge Neuropsychological Test Automated Battery
The  Cambridge  Neuropsychological  Test  Automated  Battery 
(CANTAB,  2006)  is  comprised  of  computerized  neuropsycho-
logical tests that examine various areas of cognitive function. The 
CANTAB tests are simple, computerized, non-linguistic and cultur-
ally blind, and allow us to break down executive control functions 
into cognitive components in order to define more readily which 
functions are impaired or spared. Three subtests were used in this 
study; intra–extra dimensional (ID/ED), spatial working memory 
(SWM), and stop signal task (SST), which correspond to the three 
functional areas according to Miyake et al. (2000) non-unitary 
model of executive functions.
Shifting. The ID/ED set-shift task is a test of rule acquisition and 
reversal. The task assesses the ability to maintain attention to different 
examples within a stimulus dimension (ID stages), and the ability 
to shift attention to a previously irrelevant stimulus dimension (ED 
shifts) across nine stages. Subjects proceed to the next stage when a 
criterion of six consecutive correct responses has been reached.
The two performance variables of interest are the number of 
stages completed, and the total error score adjusted for whether 
the entire task is completed (Kaplan et al., 2006).
Inhibition. The SST is a classic stop signal response inhibition test 
(Logan et al., 1984, 1997; Osman et al., 1986). It uses staircase func-
tions to generate an estimate of stop signal reaction time. The test gives 
partIcIpants
A total of 165 subjects were included in the study. From this sample, 
61 fulfilled the criteria for current primary non-psychotic unipo-
lar major depression (MDD), according to the Structured Clinical 
Interview for Diagnostic and Statistical Manual of Mental Disorders 
for Axis I (DSM-IV; APA, 1994). Of these 24 subjects fulfilled the 
MDD criteria with co-morbid anxiety disorder, whereas 37 had no 
co-morbid anxiety disorder.
The distribution of the anxiety subtypes for the MDDA group 
was: GAD = 3, SP = 13, OCD = 4, PTSD = 2, panic with agora-
phobia = 6, panic without agoraphobia = 4, specific phobia = 3, 
anxiety NOS = 2. Fourteen patients had one anxiety diagnosis, and 
10 patients had two or three anxiety disorders.
The proportion of patients medicated in each group was: MDD 
(SSRI = 12, SNRI = 1) and MDDA (SSRI = 9, SNRI = 2). In the 
MDD group, 24 were unmedicated and there were 13 unmedicated 
in the MDDA group. The HC group was unmedicated.
The number of depressive episodes was distributed as follows 
for the MDD group: 1 episode (the current one) = 20, 2 = 5, 3 = 3, 
4 = 2, 5 = 2, 6 = 1, 10 = 2, 40 = 2. For the MDDA group: 1 episode 
(the current one) = 12, 2 = 3, 3 = 2, 4 = 1, 6 = 1, 10 = 1, 15 = 1, 
above 50 episodes = 3. The MDD group had one with dysthymia 
(i.e., “double-depression”), and the MDDA group had 2 with dys-
thymia (i.e., “double-depression”). All the subjects in the MDD and 
MDDA group had a non-melancholic subtype. The distribution 
of family history of depression versus no history, were as follows: 
HC (77/15), MDD (4/33), and MDDA (6/18).
The patients were recruited from psychiatric clinics for out-
patients in the Oslo and Trondheim area. Inclusion criteria 
were: to be fluent in Norwegian, and to be taking no medica-
tion other than SSRI/SNRI. The subjects were required to be 
medication-fasting the day of testing. General exclusion crite-
ria were: a history of neurological disorders, bipolar, psycho-
sis, drug/alcohol-abuse including non-prescription OTC drugs. 
Two participants were excluded due to scaled score ≤4 on the 
Wechsler  Adult  Intelligence  Scale  Third  edition  (WAIS-III) 
subtest Similarities. For comparison, 91 healthy controls (HC) 
were selected from an original sample of 125 subjects. They 
were recruited via newspaper ads, posters and through vari-
ous private companies in the Oslo region. They were screened 
for psychopathology using SCID-I and SCID-II. Thirty-three 
subjects were excluded from the original sample of 125 due to 
the following criteria: brain injury exceeding 30 min. loss of 
consciousness (n = 2), BDI ≥ 10 (n = 9), weekly alcohol intake 
>15 IU (n = 1), daily use of drugs (n = 1), and personality dis-
order (according to DSM-IV; SCID-II; n = 2). Furthermore, 18 
participants were excluded who had had one or more depressive 
episodes in the past.
clInIcal evaluatIon
Clinical and diagnostic assessment was made in accordance with 
the structured clinical interviews for DSM-IV criteria (SCID). Both 
SCID-I and SCID-II were used by trained professional clinical psy-
chologists. In addition, the rating was blindly repeated using the 
original audio taped interviews, by an external experienced clinical 
psychologist who was unaware as to whether the participants where 
HC, MDD, or MDDA (validated by one of the co-authors: TCS).Frontiers in Psychiatry  |  Affective Disorders    December 2010  | Volume 1  | Article 149  |  4
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Differences between the groups were found regarding age 
[F(2, 152) = 6.637, p < 0.01], education level (ISCED) [F(2, 
152) = 9.67, p < 0.001], and general cognitive functioning (WAIS-
MEAN) [F(2, 152) = 14.055, p < 0.001]. There were no signifi-
cant differences between MDD and MDDA on BDI, but MDDA 
had a higher score on BAI than MDD [F(2, 151) = 115.259, 
p < 0.001].
There were no significant between-group differences in terms 
of gender [χ2 (2) = 1.85, p = 0.397] distribution and handedness 
[χ2 (4) = 8.60, p = 0.072].
The patients with MDD differed significantly from the HC group 
regarding age, the mean age being older for MDD. The MDDA 
group differed significantly from the MDD group, the mean age 
being younger for the former. There were no statistical differences 
in age between MDDA and HC.
According  to  estimated  general  cognitive  functioning,  the 
MDDA group had significantly lower mean than HC and MDD. 
The MDDA differed significantly from the HC group regarding 
education level, the former having lower mean ISCED-level.
Since  educational  level  and  estimated  general  cognitive 
functioning was correlated we did not enter the latter in the 
MANCOVA.
a measure of an individual’s ability to inhibit a prepotent response. 
The term “response inhibition” refers to cognitive processes enabling 
executive control over prepotent responses in accordance with chang-
ing situational demands. The main outcome variable of interest for 
our purpose is the stop signal reaction time (SSRT), which is an esti-
mate of the subject’s response time to the stop signal, i.e., the time it 
takes to react to the stop signal by inhibiting the prepotent response 
to the go signal (i.e., the time required to inhibit a response after it 
has been initiated). SSRT is estimated by subtracting stop signal delay 
(SSD) from mean Go signal reaction time (RTonGT).
Updating. Spatial working memory is a test of the subject’s ability 
to retain spatial information and to manipulate remembered items 
in working memory. It is a self-ordered task which requires sub-
jects to search for hidden “tokens” within a spatial array of colored 
boxes. By touching the boxes and using a process of elimination, 
the subject should find one blue “token” in each of a number of 
boxes, and then use them to fill up an empty column on the right 
hand side of the screen. The number of boxes is gradually increased 
until it is necessary to search a total of eight boxes. The color and 
position of the boxes used are changed from trial to trial in order to 
discourage the use of stereotyped search strategies. The rationale for 
this task and its implementation has been described previously in 
some detail (Owen et al., 1990). Outcome measures of interest are 
a “between” errors score, which is calculated when a subject returns 
to a square where a token was already found in a previous trial. This 
assesses the accuracy of working memory, as a strategy measure is 
derived; i.e., a subject’s ability to adopt a systematic search strategy: 
a lower strategy score reflects more efficient task performance on 
SWM (Owen et al., 1990; Weiland-Fiedler et al., 2004).
psychoMotor speed
In addition to the main variable of inhibition on the SST task, an 
outcome measure of reaction time on Go trials (GoRT), an indica-
tor of psychomotor speed, was included.
data analysIs
Data  analysis  was  completed  by  means  of  SPSS  version  16.0 
(SPSS Inc., Chicago, IL, USA). Multivariate analysis of covariance 
(MANCOVA) was first used to compare the patient groups (MDD 
and MDDA) and the HC on the combined score of the six depend-
ent variables measured at the individual level: ID/ED stages com-
pleted, ID/ED total errors adjusted, SWM strategy, SWM between 
errors, SST RT on Go trials, and SST SSRT, while simultaneously 
controlling for age, sex, and education level. Follow-up univariate 
analysis of covariance (ANCOVA) was then performed to detect 
which of the six dependent variables the three groups differed sig-
nificantly from each other in mean scores. Finally, ANCOVA was 
also used to compare the MDD group and the MDDA group on 
the six dependent variables controlling for the number of earlier 
depressive episodes and age of onset of first depressive episode.
results
A series of one-way analyses of variance (ANOVAs) and Chi-square 
tests was conducted to compare the four groups across the demo-
graphic variables, followed by post hoc tests with Bonferroni cor-
rections to determine which groups differed (Table 1).
Table 1 | Descriptive statistics for demographic variables, clinical 
characteristics, and general cognitive functioning (estimated from the 
WAIS-III subtests Similarities and Picture Completion) for patients with 
MDD, MDDA, and healthy comparison subjects.
      Healthy 
  MDD (n = 37)  MDDA (n = 24)  controls 
     ( n = 91)
  M  SD  M  SD  M  SD
Age (years)  44.2  12.3  35.5  14.2  35.8  12.0
Education (years)  15.8  3.2  13.5  2.3  16.4  2.5
BDI  21.4  11.1  25.4  7.4  2.1  2.7
BAI  11.6  8.2  18.7  6.7  2.1  2.5
Symptom-GAF  60.2  12.1  53.8  8.5  95.6  7.3
Function-GAF  63.6  13.8  55.2  10.1  96.7  5.6
General cognitive   11.1  2.1  9.3  2.6  12.1  2.4 
functioning
Age of onset first  33.5  14.4  30.1  16.1     
MDD episode
  n  %  n  %  n  %
gender
  Male  14  37.8  11  45.8  28  30.7
  Female  23  62.2  13  54.2  63  69.3
HANDeDNeSS           
  Right  35  94.6  24  100  8  42.1
  Left  1  2.7  0  0  11  57.9
Ambidextrous  1  2.7  0  0  0  0
MDD,  current  major  depressive  disorder;  BDI,  Beck  depression  inventory; 
BAI,  Beck  anxiety  inventory;  GAF ,  global  assessment  of  functioning  axis-V 
in  Diagnostic  and  statistical  manual  of  mental  disorders  –  Fourth  Edition 
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the dependent variables: ID/ED total errors adjusted and SWM 
between errors. The MDDA group performed the tasks with more 
errors than the HC.
There were significant differences between the MDD group and 
the HC group on SST RT on Go Trials. MDD performed the task 
with slower psychomotor speed compared to the HC group. There 
were no statistical significant differences between the clinical groups 
on any of the other variables.
The results and mean scores for each group are presented in 
Table 2. Profiles of the three groups on the CANTAB variables are 
presented in Figure 1.
Although there was a significant difference between the MDDA 
group and HC on the general cognitive measure, the patients nev-
ertheless performed well within the normal range. As compared to 
the formal norms the performance level equals less than one-third 
SD from the mean.
The MANCOVA demonstrated a significant overall group dif-
ference in performance on the CANTAB tests [F(12, 284) = 2370, 
p < 0.01] Follow-up ANCOVAs and post hoc tests demonstrated 
that after controlling for gender, age, and education level and 
adjusted for multiple comparisons (Bonferroni), there were sig-
nificant differences between the MDDA group and HC on two of 
Table 2 | Neuropsychological test performance on the CANTAB variables for patients with MDD, MDDA, and healthy comparison subjects (HC). 
Difference in mean scores is controlled for age, gender, and education level.
  MDD (n = 37)  MDDA (n = 24)  Healthy controls(n = 91)  Statistical analyses ANCOVA
  M  SD  M  SD  M  SD  F  df  p
SeT-SHIFT
  ID/ED; stages completed  8.4  1.6  8.3  0.9  8.7  0.7  1.399  2  0.250
  ID/ED; total errors adj.  25.8  19.4  33.0  22.0  20.4  18.0  4.255  2  0.016*
WORKINg MeMORy/uPDATINg
  SWM; between errors  25.1  17.9  27.8  18.1  16.3  15.1  4.658  2  0.011*
  SWM; strategy  32.3  6.0  33.1  5.4  30.8  6.0  1.764  2  0.175
INHIBITION
  SST; SSRT last half  189.1  64.9  202.5  74.5  180.1  50.4  1.785  2  0.171
RT/PSyCHOMOTOR SPeeD
  SST; RT on GO trials  506.1  140.8  412.3  82.7  407.7  123.7  3.701  2  0.027*
*p < 0.05.
-1.00
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Notes: ID/ED:SC= Stages Completed, ID/ED:TEA= Total Errors Adjusted, SWM:S= Strategy, SWM:BE= 
Between Errors, SST:SSRT= Stop Signal Reaction Time, SST:RTGO= RT on Go Trials
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WM in depression and anxiety represent symptom or syndrome 
factors, or an interaction of both with situational stress as a medi-
ating factor (Eysenck and Calvo, 1992; Chong, 2003; Murray and 
Janelle, 2003).
The ID/ED results indicate that the MDDA group showed more 
total errors and thus were less able than HC to learn to shift or 
switch attention to new previously irrelevant exemplars of stimuli 
or mental sets. Symptom severity on BAI, but not BDI, showed a 
significant correlation with set shifting. This indicates that self-
reported anxiety symptom severity and the set-shift function are 
linked in the MDDA group; this relates to the specific roles of 
symptom and syndrome anxiety in executive control functions.
In contrast to Basso et al. (2007), we found no significant psycho-
motor slowing in the MDDA group. However, in the MDD group 
showed reduced psychomotor speed compared to HC. The research 
field has published frequent findings of psychomotor slowing in 
both MDD and in MDDA, but to our knowledge only a few stud-
ies (Dutke and Stöber, 2001) have found more rapid psychomo-
tor speed in anxiety. There are numerous theories stating that the 
presence of anxiety yields slower processing due to an obsessive 
or ruminative approach to testing (Basso et al., 2007). Moreover, 
the profile and nature of cognitive dysfunction is hypothesized to 
depend upon anxiety subtype, and the majority of studies have 
focused mainly on OCD.
Anxiety patients often exhibit a fear of new or unfamiliar situa-
tions. Therefore the experimental situation itself is often sufficiently 
threatening to arouse a significantly greater amount of manifest 
anxiety in the anxiety group than in than the other two groups with 
depression. One may wonder if this creates a drive or motivation 
that can be measured as increased psychomotor speed. It may be 
hypothesized that in this study, it is the depression component that 
contributes to the deficits in speed, and that the lack of psycho-
motor deficit in the MDDA group was due to counterbalance by 
two inverse tendencies, or to a competition between psychomotor 
retardation and “acceleration.”
Number of earlier depressive episodes in the MDD and MDDA 
group was not significantly associated with the dependent variables. 
This result contradicts research findings where number of depres-
sive episodes seems to have a cumulative effect on cognitive control 
impairment in MDD (Vanderhasselt and De Raedt, 2009). One of 
the main hypotheses is that each repeated depressive episode “leaves 
a mark” in the brain (Sheline, 2000). Stordal et al. (2005) found 
no impairment in executive functions in about half the patients 
with recurrent MDD, although the depressed patients with execu-
tive function impairments were the ones with more episodes than 
the patients without such impairments. In line with our present 
results, other studies have found no association between number 
of episodes and performance on tests that tap executive functions 
(Reischies and Neu, 2000; Grant et al., 2001).
Regarding the notion that the MDDA group represents an addi-
tive effect in severity, studies by Purcell et al. (1997), Elliott et al. 
(1996), and Beats et al. (1996) show that both inpatients with a 
more severe history of depression and hospitalization, and eld-
erly patients may exhibit more evident set-shift deficits than do 
younger/middle-aged outpatients (Purcell et al., 1997). One reason 
why the research field has yielded different results may be that 
to our knowledge, the previous research concerning MDD with 
Furthermore, we performed two ANCOVAs to test whether there 
was a difference between the two mood disorder patient groups 
(MDD and MDDA) on the CANTAB variables when we controlled 
for the number of depressive episodes and age of onset first depres-
sive episode. (There are nine missing in the MDD group and four 
missing in the MDDA group due to difficulties in gaining accurate 
information about age of onset from these subjects).
The results showed that the number of episodes and age of onset 
was not significantly related to the dependent variables. Hence, 
including number of depressive episodes and age of onset as cov-
ariates in the analyses, did not alter the results, i.e., there were no 
significant differences in mean scores on the dependent variables 
between the two groups.
A significant Pearson correlation was found for the MDDA 
group between BAI and ID/ED; total errors adjusted (r = 0.48, 
p < 0.05). There were no significant correlations for the SWM; 
between errors. No significant correlations were found between 
BDI and the two CANTAB measures.
dIscussIon
The  current  data  indicate  that  significant  neuropsychological 
impairment in cognitive control functions corresponds with the 
presence of MDD and co-morbid anxiety. The MDDA group dis-
played significantly impaired performance with respect to working 
memory and set shifting compared to the HC. The MDD group did 
not show cognitive control dysfunctions relative to the HC, except 
for displaying slowed psychomotor speed. Contrary to expectation 
the MDDA group did not perform worse than the MDD group. 
There emerged no significant differences between any of the clini-
cal groups and HC on the ability to inhibit a prepotent response. 
Number of depressive episodes and age of onset for first depressive 
episode was not significantly related to either working memory or 
set shifting test performance.
The MDDA group displayed impairment in relation to the HC 
group on the variable assessing updating in working memory. This 
is an error score, and not the variable assessing the ability to adopt 
a systematic strategy. This indicates that it is the “pure” working 
memory that is affected. This is in concert with general theories 
of affect–cognition interactions, stating that anxiety impacts cog-
nitive load by the depletion of central executive resources, i.e., 
restrictions in WM capacity (Eysenck and Calvo, 1992; Shackman 
et al., 2006).
Negative mood and rumination require generally more atten-
tion than neutral and positive stimuli (Dolcos and McCarthy, 
2006; Van Dillen and Koole, 2007). Strong negative stimuli (as in 
major depression) may trigger more mood-congruent processing 
and thus employ more WM capacity. This interactive relationship 
between WM load and emotional intensity of negative stimuli were 
examined by Van Dillen and Koole (2007). Participants reported 
attenuated negative moods in WM trials with high demands, sug-
gesting that negative mood and WM capacity interact. Since we 
found no significant correlation between symptom severity (BAI 
or BDI) for the MDDA group on the working memory variable, 
this may indicate that it is the diagnostic validity of the clinical 
ratings of syndrome MDD and co-morbid anxiety disorder that 
is reflected in the WM impairment. This adds data to the ongoing 
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